ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation - Jeong Eun Kang; Hyun Wook Seo; Dong-Eun Kim; Young Hyun Shin; Songmee Bae; Cheol-Hee Yoon (PLoS ONE, 2025)